Cynosure Gets Australian Regulatory To Market PicoSure - Quick Facts

(RTTNews) - Cynosure, Inc. (CYNO) reported that Australia's Therapeutic Goods Administration has granted marketing clearance for the PicoSure Picosecond Laser, a picosecond laser for the removal of tattoos and benign pigmented lesions. PicoSure was introduced in the United States earlier this year after getting clearance from the U.S. Food and Drug Administration or FDA. Also, the product is being marketed in the European Union and Canada.

In addition, the firm has received approval from the China Food and Drug Administration to market Smartlipo MPX LaserBodySculpting Workstation, a laser-assisted lipolysis system designed to disrupt fat cells and tighten tissue via. tissue coagulation. Moreover, the PinPointe FootLaser, which Cynosure distributes through an exclusive worldwide deal with NuvoLase Inc., has been cleared by the Korea FDA for the treatment of Onychomycosis, commonly known as nail fungus.